A human whole-blood model to study the activation of innate immunity system triggered by nanoparticles as a demonstrator for toxicity

In this review article, we focus on activation of the soluble components of the innate immune system triggered by nonbiological compounds and stress variances in activation due to the difference in size between nanoparticles (NPs) and larger particles or bulk material of the same chemical and physic...

Full description

Bibliographic Details
Main Authors: Kristina N Ekdahl, Karin Fromell, Camilla Mohlin, Yuji Teramura, Bo Nilsson
Format: Article
Language:English
Published: Taylor & Francis Group 2019-12-01
Series:Science and Technology of Advanced Materials
Subjects:
Online Access:http://dx.doi.org/10.1080/14686996.2019.1625721
_version_ 1818018652949053440
author Kristina N Ekdahl
Karin Fromell
Camilla Mohlin
Yuji Teramura
Bo Nilsson
author_facet Kristina N Ekdahl
Karin Fromell
Camilla Mohlin
Yuji Teramura
Bo Nilsson
author_sort Kristina N Ekdahl
collection DOAJ
description In this review article, we focus on activation of the soluble components of the innate immune system triggered by nonbiological compounds and stress variances in activation due to the difference in size between nanoparticles (NPs) and larger particles or bulk material of the same chemical and physical composition. We then discuss the impact of the so-called protein corona which is formed on the surface of NPs when they come in contact with blood or other body fluids. For example, NPs which bind inert proteins, proteins which are prone to activate the contact system (e.g., factor XII), which may lead to clotting and fibrin formation or the complement system (e.g., IgG or C3), which may result in inflammation and vascular damage. Furthermore, we describe a whole blood model which we have developed to monitor activation and interaction between different components of innate immunity: blood protein cascade systems, platelets, leukocytes, cytokine generation, which are induced by NPs. Finally, we describe our own studies on innate immunity system activation induced by three fundamentally different species of NPs (two types of engineered NPs and diesel NPs) as demonstrator of the utility of an initial determination of the composition of the protein corona formed on NPs exposed to ethylenediaminetetraacetic acid (EDTA) plasma and subsequent analysis in our whole blood model.
first_indexed 2024-04-14T07:42:30Z
format Article
id doaj.art-b7c5eabce4324222a945d4a3fe2610a4
institution Directory Open Access Journal
issn 1468-6996
1878-5514
language English
last_indexed 2024-04-14T07:42:30Z
publishDate 2019-12-01
publisher Taylor & Francis Group
record_format Article
series Science and Technology of Advanced Materials
spelling doaj.art-b7c5eabce4324222a945d4a3fe2610a42022-12-22T02:05:27ZengTaylor & Francis GroupScience and Technology of Advanced Materials1468-69961878-55142019-12-0120168869810.1080/14686996.2019.16257211625721A human whole-blood model to study the activation of innate immunity system triggered by nanoparticles as a demonstrator for toxicityKristina N Ekdahl0Karin Fromell1Camilla Mohlin2Yuji Teramura3Bo Nilsson4Rudbeck LaboratoryRudbeck LaboratoryLinnaeus UniversityRudbeck LaboratoryRudbeck LaboratoryIn this review article, we focus on activation of the soluble components of the innate immune system triggered by nonbiological compounds and stress variances in activation due to the difference in size between nanoparticles (NPs) and larger particles or bulk material of the same chemical and physical composition. We then discuss the impact of the so-called protein corona which is formed on the surface of NPs when they come in contact with blood or other body fluids. For example, NPs which bind inert proteins, proteins which are prone to activate the contact system (e.g., factor XII), which may lead to clotting and fibrin formation or the complement system (e.g., IgG or C3), which may result in inflammation and vascular damage. Furthermore, we describe a whole blood model which we have developed to monitor activation and interaction between different components of innate immunity: blood protein cascade systems, platelets, leukocytes, cytokine generation, which are induced by NPs. Finally, we describe our own studies on innate immunity system activation induced by three fundamentally different species of NPs (two types of engineered NPs and diesel NPs) as demonstrator of the utility of an initial determination of the composition of the protein corona formed on NPs exposed to ethylenediaminetetraacetic acid (EDTA) plasma and subsequent analysis in our whole blood model.http://dx.doi.org/10.1080/14686996.2019.1625721coagulation systemcomplement systemcontact/kallikrein systeminflammationinnate immunitynanoparticlesprotein coronascreeningtoxicitywhole blood model
spellingShingle Kristina N Ekdahl
Karin Fromell
Camilla Mohlin
Yuji Teramura
Bo Nilsson
A human whole-blood model to study the activation of innate immunity system triggered by nanoparticles as a demonstrator for toxicity
Science and Technology of Advanced Materials
coagulation system
complement system
contact/kallikrein system
inflammation
innate immunity
nanoparticles
protein corona
screening
toxicity
whole blood model
title A human whole-blood model to study the activation of innate immunity system triggered by nanoparticles as a demonstrator for toxicity
title_full A human whole-blood model to study the activation of innate immunity system triggered by nanoparticles as a demonstrator for toxicity
title_fullStr A human whole-blood model to study the activation of innate immunity system triggered by nanoparticles as a demonstrator for toxicity
title_full_unstemmed A human whole-blood model to study the activation of innate immunity system triggered by nanoparticles as a demonstrator for toxicity
title_short A human whole-blood model to study the activation of innate immunity system triggered by nanoparticles as a demonstrator for toxicity
title_sort human whole blood model to study the activation of innate immunity system triggered by nanoparticles as a demonstrator for toxicity
topic coagulation system
complement system
contact/kallikrein system
inflammation
innate immunity
nanoparticles
protein corona
screening
toxicity
whole blood model
url http://dx.doi.org/10.1080/14686996.2019.1625721
work_keys_str_mv AT kristinanekdahl ahumanwholebloodmodeltostudytheactivationofinnateimmunitysystemtriggeredbynanoparticlesasademonstratorfortoxicity
AT karinfromell ahumanwholebloodmodeltostudytheactivationofinnateimmunitysystemtriggeredbynanoparticlesasademonstratorfortoxicity
AT camillamohlin ahumanwholebloodmodeltostudytheactivationofinnateimmunitysystemtriggeredbynanoparticlesasademonstratorfortoxicity
AT yujiteramura ahumanwholebloodmodeltostudytheactivationofinnateimmunitysystemtriggeredbynanoparticlesasademonstratorfortoxicity
AT bonilsson ahumanwholebloodmodeltostudytheactivationofinnateimmunitysystemtriggeredbynanoparticlesasademonstratorfortoxicity
AT kristinanekdahl humanwholebloodmodeltostudytheactivationofinnateimmunitysystemtriggeredbynanoparticlesasademonstratorfortoxicity
AT karinfromell humanwholebloodmodeltostudytheactivationofinnateimmunitysystemtriggeredbynanoparticlesasademonstratorfortoxicity
AT camillamohlin humanwholebloodmodeltostudytheactivationofinnateimmunitysystemtriggeredbynanoparticlesasademonstratorfortoxicity
AT yujiteramura humanwholebloodmodeltostudytheactivationofinnateimmunitysystemtriggeredbynanoparticlesasademonstratorfortoxicity
AT bonilsson humanwholebloodmodeltostudytheactivationofinnateimmunitysystemtriggeredbynanoparticlesasademonstratorfortoxicity